Searched for
CEFTRIAXONE
Venus Remedies expands Latin America presence with Argentina nod for antibioticVenus Remedies has received approval in Argentina for its antibiotic Ceftriaxone. This marks a significant step in the company's Latin Amer...- Delius Pharma gets regulatory approval to import Ceftriaxone API from ChinaDelius Pharmaceuticals has secured approval from the CDSCO to import Ceftriaxone Sodium API from China's Guangxi Kelun Pharmaceutical. This...
- Govt revises prices of 71 medicines, including those for diabetes and infections: Check new ratesThe National Pharmaceutical Pricing Authority (NPPA) has revised the prices of 71 essential drug formulations, encompassing treatments for ...
- Amid pollution woes, Asthma drug demand drives pharma retail market growth in NovemberIndia's pharmaceutical retail market rebounded in November with double-digit growth, fueled by increased demand for dermatological, cardiac...
- Medley-Cipla deal talks called off over valuation issuesThis is the second pharma merger and acquisition (M&A) transaction that has been called off or postponed recently due to market volatility ...
- Cipla, JB Chemicals, Torrent lead Rs 4,500-crore race for Medley PharmaSet up in 1969 by Sami Khatib as Medley Laboratories, the Mumbai-based privately held company, now called Medley Pharmaceuticals, ranks amo...
- Commerce ministry for imposing anti-dumping duty on pharma API from ChinaThe imposition of anti-dumping duty is permissible under the World Trade Organisation (WTO) regime. The duty is aimed at ensuring fair trad...
- India initiates probe against alleged dumping of pharma raw material by Chinese firmsNectar Life Sciences and Sterile India have filed an application before the Commerce Ministry''s investigation arm Directorate General of T...
- Antibiotic resistance in food-animals growingIndia, long associated with the spread of superbug New Delhi metallo-beta lactamase-1 and extensively drug-resistance tuberculosis, has now...
- Lupin, Sun Pharma, Glenmark recall products in USLupin is voluntarily recalling 55,000 vials and 1,60,241 boxes of anti-bacterial drug Ceftriaxone for injection in various strengths.
- Triple whammy: You can get dengue, malaria, chikungunya at the same timeResearchers at Jamia Millia Islamia (JMI) have reported two such cases in the medical journals Intervirology and Virus Disease.
- Low-cost, paper-based device can spot substandard medicinesMedications can be compromised in many different ways. For example, they may be bulked up with fillers, or they can degrade because they ar...
- Lupin recalls over 54K vials of anti-bacterial injection in USThe ongoing voluntary recall is a class III recall and is for the US and Puerto Rico, according to the latest enforcement report on USFDA s...
- Government caps price of 6 formulations packsDrug firms such as Abbott Healthcare, Ipca Laboratories and Merck would be impacted by National Pharmaceutical Pricing Authority's (NPPA) m...
- Pharma pricing authority NPPA puts cap on 18 formulations packs’ pricesFirms such as Cipla, Alembic Pharma and Unichem Laboratories will be impacted by the government's move for prices fixation and revision.
- Prices of essential drugs may drop by 30-70%The government is likely to revise the plan to have a comprehensive new drug policy, which would extend a milder form of price control to 3...
- Aurobindo Pharma gets USFDA approval for CeftriaxoneDrug maker Aurobindo Pharma on Friday said it has recieved US regulatory approval for two drug applications in that country used in the tre...
- Wockhardt gets USFDA nod fot CeftriaxoneWockhardt will now be able to market the full range of its potent antibiotic injection, Ceftriaxone, in America as it has received the US F...
- Generics market may lose value on margin cutThe proposed trade margin cut on generic drugs from October 2 is set to be applicable to 2,000 brands of specified strengths, and as a resu...
- Medicines likely to get cheaper by 10-70%Prices of costly “essential” medicines are set to fall by 30% to 70% and that of low end brands may fall by 10% to 30%, once the new drug p...
Load More
